ClinicalTrials.Veeva

Menu

National Wilm's Tumor Study Late Effects

Emory University logo

Emory University

Status

Withdrawn

Conditions

Wilm's Tumor

Treatments

Other: none, screening only

Study type

Interventional

Funder types

Other

Identifiers

NCT00228696
IRB00024842

Details and patient eligibility

About

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Full description

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good health, some may be at risk for certain health conditions. We are collecting information from as many participants as possible in order to determine if they or their offspring are at risk for adverse medical conditions. If there is more than one case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate heritability and recurrence risks.

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Previously enrolled in NWTS 5.

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

screening
No Intervention group
Description:
this is a screening study and no intervention.
Treatment:
Other: none, screening only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems